Chemocare.com uses trade names in all descriptions of drugs. Zydelig® is the trade name for the generic chemotherapy drug idelalisib. In some cases, health care professionals may use the generic name idelalisib when referring to the trade drug Zydelig®.
Drug type: Zydelig® is a targeted therapy. It is an oral Phosphatidylinositol 3-kinase inhibitor – (For more detail, see “How this drug works,” below).
What Zydelig Is Used For:
Chronic lymphocytic leukemia: Treatment of relapsed chronic lymphocytic leukemia (CLL) (in combination with rituximab) when rituximab alone is appropriate therapy due to other comorbidities.
Follicular B-cell non-Hodgkin lymphoma: Treatment of relapsed follicular B-cell non-Hodgkin lymphoma after at least 2 prior systemic therapies.
Small lymphocytic lymphoma: Treatment of relapsed small lymphocytic lymphoma (SLL) after at least 2 prior systemic therapies.